Tamponade: Difference between revisions

Jump to navigation Jump to search
m (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +))
 
m (Robot: Automated text replacement (-{{reflist}} +{{reflist|2}}, -<references /> +{{reflist|2}}, -{{WikiDoc Cardiology Network Infobox}} +))
Line 1: Line 1:
{{WikiDoc Cardiology Network Infobox}}
 
{{SI}}
{{SI}}
{{CMG}}
{{CMG}}

Revision as of 15:24, 6 September 2012

WikiDoc Resources for Tamponade

Articles

Most recent articles on Tamponade

Most cited articles on Tamponade

Review articles on Tamponade

Articles on Tamponade in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Tamponade

Images of Tamponade

Photos of Tamponade

Podcasts & MP3s on Tamponade

Videos on Tamponade

Evidence Based Medicine

Cochrane Collaboration on Tamponade

Bandolier on Tamponade

TRIP on Tamponade

Clinical Trials

Ongoing Trials on Tamponade at Clinical Trials.gov

Trial results on Tamponade

Clinical Trials on Tamponade at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Tamponade

NICE Guidance on Tamponade

NHS PRODIGY Guidance

FDA on Tamponade

CDC on Tamponade

Books

Books on Tamponade

News

Tamponade in the news

Be alerted to news on Tamponade

News trends on Tamponade

Commentary

Blogs on Tamponade

Definitions

Definitions of Tamponade

Patient Resources / Community

Patient resources on Tamponade

Discussion groups on Tamponade

Patient Handouts on Tamponade

Directions to Hospitals Treating Tamponade

Risk calculators and risk factors for Tamponade

Healthcare Provider Resources

Symptoms of Tamponade

Causes & Risk Factors for Tamponade

Diagnostic studies for Tamponade

Treatment of Tamponade

Continuing Medical Education (CME)

CME Programs on Tamponade

International

Tamponade en Espanol

Tamponade en Francais

Business

Tamponade in the Marketplace

Patents on Tamponade

Experimental / Informatics

List of terms related to Tamponade

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


For more information, see the chapter on Diseases of the pericardium

Overvew

Tamponade is defined as hemodynamically significant compression by accumulating pericardial contents that evoke and defeat compensatory mechanisms.

Pathophysiology & Etiology

  • Cardiac tamponade occurs when increasing pericardial pressure leads to decreased left ventricular volume and elevated diastolic pressures. This elevation in diastolic pressure impairs LV filling leading to diminished stroke volume and blood pressure. The transmural or distending pressure is equal to the intracavitary pressure minus the pericardial pressure. Normally, pericardial pressure is negative and the filling is favored. When pericardial pressure becomes more and more positive, the distending pressure is diminished and the chamber collapses.
  • The compensatory mechanisms are aimed at maintaining perfusion and cardiac output. Over time, blood volume increases. Adrenergic stimulation leads to increased inotropy and ejection fraction as well as tachycardia and increased systemic vascular resistance.
  • There are many causes of pericardial effusions with frequencies varying depending on the population studied. The major causes include infection, infarction, trauma, AIDS, malignancy, radiation, collagen vascular disease, uremia, hypothyroidism, drugs, post-CABG and others. Diagnostic pericardiocentesis has a 6% yield. If the fluid is removed therapeutically, it is diagnostic 1/3 of the time.
  • In a series of 75 patients presenting to a tertiary care medical center, 25% were malignant, 27% infectious, 12% related to rheumatologic disease and 14% to radiation. AIDS has become the leading cause of pericardial effusion in many hospitals and is associated with shortened survival. Pericardial effusion is the most common initial, cardiovascular manifestation of HIV disease.
    • Malignant effusions
      • Virtually every neoplasm has been reported to metastasize to the pericardium. In a study of 789 patients with pericardial metastases, 37% were lung, 22% breast and 17% hematologic. The majority was found only at autopsy and was not clinically significant. The incidence of tamponade in those with metastatic disease to the heart is approximately 15%. Of cancer patients with effusions, 70% are malignant with only 45% being bloody at drainage. Cytology is positive in 80%, while pericardial biopsy is positive in only 55%.
  • Hemodynamic Manifestations: The hallmark is equalization of diastolic pressures. PCWP, RAP, RVEDP, LVEDP and pericardial pressures equalize usually to within 1-2 mm Hg. The RAP is elevated and the pressure waveform demonstrates an accentuated x descent and an attenuated y descent. As little as 50cc of fluid can cause tamponade if accumulation is rapid, while >1500cc can drain from patients who are otherwise hemodynamically stable.
    • Pulsus Paradoxus: A greater than normal decline in arterial systolic pressure with inspiration. The paradox refers to Kussmaul’s finding that intermittently the pulse was not palpable despite continued heart sounds. Increased right ventricular filling during inspiration and resultant interventricular septal bulging leading to impaired left ventricular filling is the most often quoted mechanism. A pulsus may be present in nontamponade disorders such as COPD, severe hypovolemic shock, RV infarction, and PE. Tamponade without pulsus paradoxus occurs in those with preexisting elevation of left or right ventricular diastolic pressures (PHTN, CHF, LVH, ASD, severe AI).

Diagnosis

Clinical features of tamponade and echocardiographic findings make the diagnosis.

History and Symptoms

  • Patients symptoms are commonly nonspecific and related to the underlying disorder.
  • Common complaints are:
  • Symptoms do not correlate with the size of the effusion.
  • In a study of 56 patients with tamponade, about 40 had a pulsus >20 mmHg and/or tachycardia.
    • 52 had an enlarged cardiac silhouette on chest x-ray.
    • The blood pressure was >100 mmHg in 36.
    • A rub was found in 16 and Beck’s triad was only seen in 19 (more commonly seen in trauma).
    • Electrical alternans is seen in approximately 5% and low voltage in 60%.

Physical Examination

Appearance of the Patient

Heart

Quiet muffled heart sounds are present.

Electrocardiogram

The voltage may be reduced and there is a rotation of the electrical axis. Tachycardia is often present.

Chest X Ray

An enlarged cardiac silhouette may be seen.

Echocardiography or Ultrasound

Echocardiographic findings of tamponade include seeing the effusion and evidence of RA (right atrium), RV (right ventricle) diastolic, LA (left atrium) or LV (left ventricle) collapse. As can be inferred from the pathophysiology, other finding include seeing reciprocal respiratory variations in LV and RV chamber size; increased flow across the tricuspid valve with reciprocal decrease across the mitral valve during inspiration; reduced collapse of the IVC during inspiration; and septal bulging. RV and RA collapse are the most useful findings. PTHN, RVH and TR may eliminate these findings. RV diastolic collapse occurs when the C.O. falls by about 1/5.

Treatment

Tamponade presents as a spectrum of illness. There is not much debate in the treatment of the very sick or the asymptomatic patient. The debate occurs in those with echocardiographic evidence of tamponade but no clinical findings. A prudent strategy in these cases is to observe the progression of the disease process and intervene at the onset of any evidence of compromise. Volume repletion, serial echocardiographic and clinical assessment is warranted in these cases.

Pharmacotherapy

Intravenous fluids are helpful to treat hypotension.

Surgery and Device Based Therapy

See the chapter on Pericardiocentesis

References

[1] [2] [3]

Acknowledgements

The content on this page was first contributed by: Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2] and Resident Report by Duane Pinto.

List of contributors: C. Michael Gibson, M.S., M.D.


Suggested Reading and Key General References

Suggested Links and Web Resources

For Patients


Template:WikiDoc Sources

  1. Press OP, Livingston R. Management of Malignant Pericardial Effusion. JAMA. 1987; 257:1088-1092.
  2. Ameli S, Shah PK. Cardiac Tamponade: Pathophysiology, Diagnosis and Management. Cardiology Clinics. 1991; 665-674.
  3. Spodick DH. The Normal and Diseased Pericardium: Current Concepts of Pericardial Physiology, Diagnosis and Treatment. JACC. 1983; 240-251.